A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [¹⁷⁷Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial

Search results

• Recent Findings from Catholic University of Korea Has Provided New Information about Prostate Cancer (A Single Dose of Novel Psma-targeting Radiopharmaceutical Agent [Lu-177]Ludotadipep for Patients With Metastatic Castration-resistant Prostate ...)

  Ha, S. G., Lee, J. Y., Yoo, I. R. & Moon, H. W.

  20/01/23

  1 item of Media coverage

  Press/Media

• Catholic University of Korea Researchers Detail New Studies and Findings in the Area of Prostate Cancer (A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu]Ludotadipep for Patients with Metastatic Castration-Resistant ...)

  Ha, S. G., O, J. H., Lee, J. Y., Yoo, I. R. & Moon, H. W.

  5/01/23

  1 item of Media coverage

  Press/Media